Free Trial

Merck KGaA (OTCMKTS:MKGAF) Stock Passes Below 50-Day Moving Average - Should You Sell?

Merck KGaA logo with Medical background

Merck KGaA (OTCMKTS:MKGAF - Get Free Report) shares crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $151.41 and traded as low as $146.25. Merck KGaA shares last traded at $146.25, with a volume of 144 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, The Goldman Sachs Group upgraded Merck KGaA to a "strong-buy" rating in a research report on Thursday, September 19th.

View Our Latest Stock Report on MKGAF

Merck KGaA Price Performance

The firm has a 50-day moving average of $151.03 and a 200 day moving average of $168.04. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. The company has a market capitalization of $19.12 billion, a PE ratio of 22.58 and a beta of 0.96.

About Merck KGaA

(Get Free Report)

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.

Read More

Should You Invest $1,000 in Merck KGaA Right Now?

Before you consider Merck KGaA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.

While Merck KGaA currently has a "Strong Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines